Robert Tansley

Robert Tansley is a prominent partner at Cambridge Innovation Capital plc since January 2014, specializing in investments that support leading life sciences and technology companies linked to the University of Cambridge. Tansley holds multiple board member roles at various companies, including T-Therapeutics Ltd, Pretzel Therapeutics, Exvastat, Microbiotica, and previously at PetMedix and Abcodia Limited. Additionally, Tansley serves as a board observer at Carrick Therapeutics and has held previous roles at CMR Surgical and Inivata. Academic qualifications include an M.Phil in Epidemiology & Biostatistics from the University of Cambridge, an MBA from London Business School, an MBBS in Medicine from UCL, and a Diploma of Pharmaceutical Medicine alongside an MRCOG from the Royal College of Obstetricians and Gynaecologists.